Sec. 90203. NATIONAL DRUG CONTROL STRATEGY OUTCOME MEASURES

926 words·~4 min read·/statute-compilations/comps-10824/sec-90203

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 90203 NATIONAL DRUG CONTROL STRATEGY OUTCOME MEASURES Section 1005(a) of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1504(a)) is amended— ####

(1)in paragraph (2)(A) by inserting “and the consequences of drug abuse” after “drug abuse”; and ####

(2)by amending paragraph

(4)to read as follows: > > #### “(4) > > The Director shall include with each National Drug Control Strategy an evaluation of the effectiveness of Federal drug control during the preceding year. The evaluation shall include an assessment of Federal drug control efforts, including— > > > ##### “(A) > > assessment of the reduction of drug use, including estimates of drug prevalence and frequency of use as measured by national, State, and local surveys of illicit drug use and by other special studies of— > > > ###### “(i) > > high-risk populations, including school dropouts, the homeless and transient, arrestees, parolees, and probationers, and juvenile delinquents; and > > > ###### “(ii) > > drug use in the workplace and the productivity lost by such use; > > > ##### “(B) > > assessment of the reduction of drug availability, as measured by— > > > ###### “(i) > > the quantities of cocaine, heroin, and marijuana available for consumption in the United States; > > > ###### “(ii) > > the amount of cocaine and heroin entering the United States; > > > ###### “(iii) > > the number of hectares of poppy and coca cultivated and destroyed; > > > ###### “(iv) > > the number of metric tons of heroin and cocaine seized; > > > ###### “(v) > > the number of cocaine processing labs destroyed; > > > ###### “(vi) > > changes in the price and purity of heroin and cocaine; > > > ###### “(vii) > > the amount and type of controlled substances diverted from legitimate retail and wholesale sources; and > > > ###### “(viii) > > the effectiveness of Federal technology programs at improving drug detection capabilities at United States ports of entry; > > > ##### “(C) > > assessment of the reduction of the consequences of drug use and availability, which shall include estimation of— > > > ###### “(i) > > burdens drug users placed on hospital emergency rooms in the United States, such as the quantity of drug-related services provided; > > > ###### “(ii) > > the annual national health care costs of drug use, including costs associated with people becoming infected with the human immunodeficiency virus and other communicable diseases as a result of drug use; > > > ###### “(iii) > > the extent of drug-related crime and criminal activity; and > > > ###### “(iv) > > the contribution of drugs to the underground economy, as measured by the retail value of drugs sold in the United States; and > > > ##### “(D) > > determination of the status of drug treatment in the United States, by assessing— > > > ###### “(i) > > public and private treatment capacity within each State, including information on the number of treatment slots available in relation to the number actually used, including data on intravenous drug users and pregnant women; > > > ###### “(ii) > > the extent, within each State, to which treatment is available, on demand, to intravenous drug users and pregnant women; > > > ###### “(iii) > > the number of drug users the Director estimates could benefit from treatment; and > > > ###### “(iv) > > the success of drug treatment programs, including an assessment of the effectiveness of the mechanisms in place federally, and within each State, to determine the relative quality of substance abuse treatment programs, the qualifications of treatment personnel, and the mechanism by which patients are admitted to the most appropriate and cost effective treatment setting. > > > #### “(5) > > The Director shall include with the National Drug Control Strategy required to be submitted not later than February 1, 1995, and with every second such strategy submitted thereafter— > > > ##### “(A) > > an assessment of the quality of current drug use measurement instruments and techniques to measure supply reduction and demand reduction activities; > > > ##### “(B) > > an assessment of the adequacy of the coverage of existing national drug use measurement instruments and techniques to measure the casual drug user population and groups at-risk for drug use; > > > ##### “(C) > > an assessment of the actions the Director shall take to correct any deficiencies and limitations identified pursuant to subparagraphs

(A)and (B); and > > > ##### “(D) > > identification of the specific factors that restrict the availability of treatment services to those seeking it and proposed administrative or legislative remedies to make treatment available to those individuals. > > > #### “(6) > > Federal agencies responsible for the collection or estimation of drug-related information required by the Director shall cooperate with the Director, to the fullest extent possible, to enable the Director to satisfy the requirements of sections 4 and 5. > > > #### “(7) > > With each National Drug Control Strategy, the Director shall report to the President and the Congress on the Director's assessment of drug use and availability in the United States, including an estimate of the effectiveness of interdiction, treatment, prevention, law enforcement, and international programs under the National Drug Control Strategy in effect in the preceding year in reducing drug use and availability.” > .

Connections1 off-index

1 reference not yet in our index

21 USC 1504(a)

Citation graph

cites case law

Sec. 90203

NATIONAL DRUG CONTROL STRATEGY OUTCOME MEASURES

Cite21 USC 1504(a)

Cites 1Cited by 0 across 0 sources